Table of Contents
GOUVERNEUR, N.Y. – Kinney Drugs has received notification that the FDA has approved the Moderna COVID-19 (2024-2025 formula, KP.2) vaccine for those 12 years and older and has authorized the Moderna COVID-19 (2024-2025 formula, KP.2) vaccine for those aged six months through 11 years. Kinney Drugs expects to open appointments to administer the 2024-2025 seasonal COVID-19 vaccine early next week.
All individuals aged six months and older are eligible for the newly approved vaccine. Pharmacies such as Kinney Drugs are authorized to administer the vaccine to individuals aged 3 years and older. The newly approved COVID-19 vaccine can be co-administered with all other approved vaccines.
Those wishing to receive the company’s “Be The First to Know” notification when appointments open may sign up at: https://kinneydrugs.com/pharmacy/email-sign-up/.
“As a pharmacist, I am pleased that the FDA has approved this updated COVID-19 vaccine,” said John Marraffa, president of Kinney Drugs. “Incidents of COVID-19 are already increasing throughout both New York and Vermont, so it is especially good timing with students heading back to school. In preparation, Kinney stores are also well-stocked with over-the-counter COVID tests. Kinney Drugs remains committed and determined to protect our communities against COVID-19.”
